Shu Yao

670 total citations
17 papers, 432 citations indexed

About

Shu Yao is a scholar working on Reproductive Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Shu Yao has authored 17 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Reproductive Medicine, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Shu Yao's work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Nanoplatforms for cancer theranostics (3 papers). Shu Yao is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Nanoplatforms for cancer theranostics (3 papers). Shu Yao collaborates with scholars based in China, Sweden and Germany. Shu Yao's co-authors include Kun Song, Xuantao Su, Beihua Kong, Zhong Ping Qin, Li Ren, Li‐Ping Sun, Dong Li, Chao Lan, Jianlu Wei and Ran Chu and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and Green Chemistry.

In The Last Decade

Shu Yao

16 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Yao China 12 147 110 93 75 70 17 432
Zhumei Cui China 19 420 2.9× 77 0.7× 150 1.6× 152 2.0× 66 0.9× 43 739
Eloy Yinwang China 12 137 0.9× 40 0.4× 75 0.8× 84 1.1× 17 0.2× 23 397
Shiqiang Zhang China 13 128 0.9× 52 0.5× 71 0.8× 51 0.7× 38 0.5× 30 404
Naifu Liu China 12 118 0.8× 52 0.5× 85 0.9× 56 0.7× 60 0.9× 31 374
Jinjie Wu China 14 161 1.1× 35 0.3× 64 0.7× 171 2.3× 213 3.0× 22 537
Fen Fu China 12 164 1.1× 38 0.3× 64 0.7× 54 0.7× 13 0.2× 29 465
María Loreto Bravo Chile 10 117 0.8× 25 0.2× 118 1.3× 54 0.7× 46 0.7× 21 375
Tankut G. Güney United Kingdom 6 147 1.0× 56 0.5× 88 0.9× 41 0.5× 39 0.6× 7 318
Laura Vertechy Italy 10 96 0.7× 70 0.6× 121 1.3× 23 0.3× 146 2.1× 26 355
Lidan Zhu China 10 130 0.9× 30 0.3× 74 0.8× 79 1.1× 11 0.2× 31 375

Countries citing papers authored by Shu Yao

Since Specialization
Citations

This map shows the geographic impact of Shu Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Yao more than expected).

Fields of papers citing papers by Shu Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Yao. The network helps show where Shu Yao may publish in the future.

Co-authorship network of co-authors of Shu Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Yao. A scholar is included among the top collaborators of Shu Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Yao. Shu Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Bu, Hualei, Yuanjian Wang, Ran Chu, et al.. (2024). Association between coffee and tea consumption and ovarian cancer incidence: A prospective analysis in the PLCO dataset. International Journal of Cancer. 155(6). 1033–1044. 2 indexed citations
3.
Liu, Jiale, Yana Ma, Ran Chu, et al.. (2024). STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs). Cancer Letters. 588. 216700–216700. 19 indexed citations
5.
Liu, Bin, Xiaolei Zhang, Jinkai Li, et al.. (2022). X-ray-Triggered CO Release Based on GdW10/MnBr(CO)5 Nanomicelles for Synergistic Radiotherapy and Gas Therapy. ACS Applied Materials & Interfaces. 14(6). 7636–7645. 19 indexed citations
6.
Liu, Bin, Xiaolei Zhang, Shu Yao, et al.. (2022). X-ray triggered pea-shaped LuAG:Mn/Ca nano-scintillators and their applications for photodynamic therapy. Journal of Materials Chemistry B. 10(33). 6380–6391. 2 indexed citations
7.
Qiu, Chunping, Xun Zhang, Shu Yao, et al.. (2022). HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer. International Journal of Biological Sciences. 18(3). 1188–1210. 19 indexed citations
8.
Meng, Jinyu, Jin Peng, Jie Feng, et al.. (2021). Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer. Journal of Translational Medicine. 19(1). 415–415. 38 indexed citations
9.
Chu, Ran, Zhongshao Chen, Jinyu Meng, et al.. (2021). Progress in the management of ovarian granulosa cell tumor: A review. Acta Obstetricia Et Gynecologica Scandinavica. 100(10). 1771–1778. 17 indexed citations
10.
Wang, Zheng, Shu Yao, Kun Song, et al.. (2020). A bio-based benzoxazine surfactant from amino acids. Green Chemistry. 22(11). 3481–3488. 29 indexed citations
11.
Xie, Lin, Ran Chu, Kai Wang, et al.. (2020). Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach. Frontiers in Oncology. 10. 1353–1353. 17 indexed citations
12.
Zhang, Jinhua, Zhanghua Han, Cunzhong Yuan, et al.. (2020). Label-free characterization of cancerous ovarian tissues with continuous wave terahertz spectroscopy. 36–36. 2 indexed citations
13.
Yao, Shu, Li Li, Xuantao Su, et al.. (2018). Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo. Journal of Experimental & Clinical Cancer Research. 37(1). 29–29. 40 indexed citations
14.
Huang, Zhen, Li Li, Shu Yao, et al.. (2018). Diagnostic accuracy of frozen section analysis of borderline ovarian tumors: a meta-analysis with emphasis on misdiagnosis factors. Journal of Cancer. 9(16). 2817–2824. 17 indexed citations
15.
Li, Jie, Shu Yao, Kai Wang, et al.. (2018). Hypocrellin B‐loaded, folate‐conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo. Cancer Science. 109(6). 1958–1969. 22 indexed citations
16.
Sun, Li‐Ping, Dong Li, Kun Song, et al.. (2017). Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro. Scientific Reports. 7(1). 2552–2552. 116 indexed citations
17.
Qin, Zhong Ping, et al.. (1998). Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 86(2). 139–144. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026